US Stock MarketDetailed Quotes
VCNX Vaccinex
- 4.8600
- +0.0600+1.25%
Close Apr 19 16:00 ET
- 4.8000
- -0.0600-1.23%
Post 18:33 ET
7.70MMarket Cap-111P/E (TTM)
5.0099High4.6300Low7.91KVolume4.6300Open4.8000Pre Close38.10KTurnover1.04%Turnover RatioLossP/E (Static)1.58MShares100.800052wk High-3.33P/B3.70MFloat Cap4.432052wk Low--Dividend TTM760.55KShs Float2568.3000Historical High--Div YieldTTM7.92%Amplitude4.4320Historical Low4.8180Avg Price1Lot Size
About Vaccinex Company
Vaccinex, Inc. operates as a clinical-stage biotechnology company. It engages in the development of targeted bio therapeutics to treat serious diseases and conditions with unmet medical needs, including cancer, neurodegenerative diseases, and autoimmune disorders. The firm focuses on the development of Pepinemab for the treatment of non-small cell lung cancer, or NSCLC, osteosarcoma, melanoma, and Huntington’s disease. Its product pipeline includes the SEMA4D antibody platform and ActivMAb antibody discovery platform. The company was founded by Maurice Zauderer in April 2001 and is headquartered in Rochester, NY.
Company Profile
SymbolVCNX
Company NameVaccinex
Listing DateAug 9, 2018
Issue Price12.00
Founded2001
CEODr. Maurice Zauderer, PhD
MarketNASDAQ
Employees40
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address1895 Mount Hope Avenue
CityRochester
ProvinceNew York
CountryUnited States of America
Zip Code14620
Phone1-585-271-2700
Websitehttp://www.vaccinex.com
Company Executives
- Name
- Position
- Salary
- Dr. Maurice Zauderer, PhD
- Director, President and Chief Executive Officer
- 430.28K
- Jill Sanchez
- Interim Chief Financial Officer and Principal Accounting Officer
- --
- Elizabeth Evans
- Chief Operating Officer and Senior Vice President, Translational Medicine and Discovery
- 303.21K
- Dr. Ernest S. Smith, PhD
- Senior Vice President, Research and Chief Scientific Officer
- 308.90K
- Albert D. Friedberg
- Chairman of the Board
- 75.00K
- Chrystyna Bedrij Stecyk
- Independent Director
- 75.00K
- Dr. Bala S. Manian, PhD
- Independent Director
- 82.50K
- Barbara Yanni
- Independent Director
- 85.00K
- Jacob B. Frieberg
- Independent Director
- 75.00K
- Gerald E. Van Strydonck
- Independent Director
- 90.00K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg